Results 21 to 30 of about 681,499 (122)
Patient‐reported outcomes for monitoring substance use treatment: A systematic review of single‐item measures
Addiction, Volume 121, Issue 9, Page 2292-2316, September 2026.Abstract Background and aims
Measurement‐based care (MBC) is a structured approach using standardized, repeated assessments to monitor treatment progress and guide clinical decision‐making. MBC improves outcomes for substance use treatment but can be time consuming due in part to lengthy assessment tools. Single‐item, patient‐reported outcome measures (Thomas J. Reese, Hilary A. Tindle, Justin Bachmann, Adam Wright, Jessica S. Ancker, Carolyn M. Audet, Mauli V. Shah, Bryan D. Steitz, Michael H. Levin, Kristopher A. Kast, David Marcovitz, Amanda von Horn, A. Taylor Kelley, John F. P. Bridges +13 morewiley +1 more sourceThe As and Bs of titi monkey linguistics: why emotional communication is not the enemy
Biological Reviews, Volume 101, Issue 3, Page 1479-1490, June 2026.ABSTRACT
The alarm call sequences of titi monkeys (genera Plecturocebus, Callicebus and Cheracebus) have sparked important debates over whether they exhibit parallels with human language. Some researchers consider these sequences to involve both semantics and syntax, while others argue that the sequences convey semantic information without syntax.Mélissa Berthet, Geoffrey Mesbahi, Maël Leroux +2 morewiley +1 more sourceImmune Priming and the Risk of COVID‐19, Influenza, and Other Acute Respiratory Infections: Insights From an N3C Cohort
Influenza and Other Respiratory Viruses, Volume 20, Issue 3, March 2026.ABSTRACT Background
The emergence of SARS‐CoV‐2 and introduction of COVID‐19 vaccines into immunologically naïve populations may alter the dynamics of other acute viral respiratory infections (viral ARIs) and vice versa. Competing forces, including viral interference, cross‐reactive immunity, shared susceptibility, and immune dysregulation, may affect ...Tomás M. León, Lyndsey M. Muehling, Rachel Baccile, Olga Morozova, National Clinical Cohort Collaborative (N3C) COVID‐19 Consortium, Christopher G. Chute, Adam B. Wilcox, Adam M. Lee, Alexis Graves, Alfred Anzalone, Amin Manna, Amit Saha, Amy Olex, Andrea Zhou, Andrew E. Williams, Andrew M. Southerland, Andrew T. Girvin, Anita Walden, Anjali Sharathkumar, Benjamin Amor, Benjamin Bates, Brian Hendricks, Brijesh Patel, G. Caleb Alexander, Carolyn T. Bramante, Cavin Ward‐Caviness, Charisse Madlock‐Brown, Christine Suver, Christopher G. Chute, Christopher Dillon, Chunlei Wu, Clare Schmitt, Cliff Takemoto, Dan Housman, Davera Gabriel, David A. Eichmann, Diego Mazzotti, Donald E. Brown, Eilis Boudreau, Elaine L. Hill, Emily Carlson Marti, Emily R. Pfaff, Evan French, Farrukh M. Koraishy, Federico Mariona, Fred Prior, George Sokos, Greg Martin, Harold P. Lehmann, Heidi Spratt, Hemalkumar B. Mehta, J. W. Awori Hayanga, Jami Pincavitch, Jaylyn Clark, Jeremy Richard Harper, Jessica Yasmine Islam, Jin Ge, Joel Gagnier, Johanna J. Loomba, John B. Buse, Jomol Mathew, Joni L. Rutter, Julie A. McMurry, Justin Guinney, Justin Starren, Karen Crowley, Katie Rebecca Bradwell, Kellie M. Walters, Ken Wilkins, Kenneth R. Gersing, Kenrick Cato, Kimberly Murray, Kristin Kostka, Lavance Northington, Lee Pyles, Lesley Cottrell, Lili M. Portilla, Mariam Deacy, Mark M. Bissell, Marshall Clark, Mary Emmett, Matvey B. Palchuk, Melissa A. Haendel, Meredith Adams, Meredith Temple‐O’Connor, Michael G. Kurilla, Michele Morris, Nasia Safdar, Nicole Garbarini, Noha Sharafeldin, Ofer Sadan, Patricia A. Francis, Penny Wung Burgoon, Philip R. O. Payne, Randeep Jawa, Rebecca Erwin‐Cohen, Rena C. Patel, Richard A. Moffitt, Richard L. Zhu, Rishikesan Kamaleswaran, Robert Hurley, Robert T. Miller, Saiju Pyarajan, Sam G. Michael, Samuel Bozzette, Sandeep K. Mallipattu, Satyanarayana Vedula, Scott Chapman, Shawn T. O’Neil, Soko Setoguchi, Stephanie S. Hong, Steven G. Johnson, Tellen D. Bennett, Tiffany J. Callahan, Umit Topaloglu, Valery Gordon, Vignesh Subbian, Warren A. Kibbe, Wenndy Hernandez, Will Beasley, Will Cooper, William Hillegass, Xiaohan Tanner Zhang +122 morewiley +1 more sourceAssessment of genetically modified soybean MON 94313 (application GMFF‐2022‐6595)
EFSA Journal, Volume 24, Issue 1, January 2026.Abstract
Genetically modified soybean MON 94313 was developed to confer tolerance to dicamba, glufosinate, 2,4‐D and mesotrione‐based herbicides. These properties were achieved by introducing the dmo, pat, ft_t.1 and tdo expression cassettes. The molecular characterisation data and bioinformatics analyses do not identify issues requiring food/feed ...EFSA Panel on Genetically Modified Organisms (GMO), Josep Casacuberta, Francisco Barro, Albert Braeuning, Ruud de Maagd, Michelle M. Epstein, Thomas Frenzel, Jean‐Luc Gallois, Frits Koning, Antoine Messéan, F. Javier Moreno, Fabien Nogué, Giovanni Savoini, Alan H. Schulman, Christoph Tebbe, Eve Veromann, Michele Ardizzone, Giacomo De Sanctis, Antonio Fernandez Dumont, Arianna Ferrari, Andrea Gennaro, Aina Belen Gil Gonzalez, José Ángel Gómez Ruiz, Tilemachos Goumperis, Dafni Maria Kagkli, Paolo Lenzi, Aleksandra Lewandowska, Ana M. Camargo, Franco Maria Neri, Pietro Piffanelli, Tommaso Raffaello, Elena Sánchez‐Brunete +31 morewiley +1 more sourceThe soybean growth cycle: Important risks and management strategies
Crop, Forage &Turfgrass Management, Volume 11, Issue 2, December 2025.Abstract
Optimal soybean [Glycine max (L.) Merr.] production requires accurate, stage‐specific management practices to mitigate abiotic and biotic stressors. From emergence to full maturity, a soybean plant's physiological needs and vulnerabilities change as it transitions through its vegetative and reproductive cycles.David Moseley, Shaun Casteel, Shawn Conley, David Holshouser, Chad Lee, Mark A. Licht, Laura E. Lindsey, Hans Kandel, Jonathan Kleinjan, Carrie Knott, Seth Naeve, Emerson Nafziger, Michael Plumblee, Jeremy Ross, Maninder Singh, Rachel Vann, Haleigh J. Ortmeier‐Clarke +16 morewiley +1 more sourceAssessment of genetically modified soybean MON 94637 (application GMFF‐2023‐21116)
EFSA Journal, Volume 23, Issue 10, October 2025.Abstract
Genetically modified soybean MON 94637 was developed to provide protection against targeted lepidopteran pests. These properties were achieved by introducing the cry1A.2 and cry1B.2 expression cassettes. The molecular characterisation data and bioinformatic analyses do not identify issues requiring food/feed safety assessment.EFSA Panel on Genetically Modified Organisms (GMO), Josep Casacuberta, Francisco Barro, Albert Braeuning, Ruud de Maagd, Michelle M. Epstein, Thomas Frenzel, Jean‐Luc Gallois, Frits Koning, Antoine Messéan, F. Javier Moreno, Fabien Nogué, Giovanni Savoini, Alan H. Schulman, Christoph Tebbe, Eve Veromann, Michele Ardizzone, Giacomo De Sanctis, Antonio Fernandez, Arianna Ferrari, Andrea Gennaro, José Ángel Gómez Ruiz, Tilemachos Goumperis, Sara Jacchia, Dafni Maria Kagkli, Paolo Lenzi, Aleksandra Lewandowska, Ana M. Camargo, Franco Maria Neri, Pietro Piffanelli, Tommaso Raffaello +30 morewiley +1 more sourceAssociations between COVID‐19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS‐CoV‐2 variants
The Journal of Rural Health, Volume 41, Issue 1, Winter 2025.Abstract Purpose
To investigate the enduring disparities in adverse COVID‐19 events between urban and rural communities in the United States, focusing on the effects of SARS‐CoV‐2 vaccination and therapeutic advances on patient outcomes. Methods
Using National COVID Cohort Collaborative (N3C) data from 2021 to 2023, this retrospective cohort study ...A. Jerrod Anzalone, William H. Beasley, Kimberly Murray, William B. Hillegass, Makayla Schissel, Michael T. Vest, Scott A. Chapman, Ronald Horswell, Lucio Miele, J. Zachary Porterfield, H. Timothy Bunnell, Bradley S. Price, Sharon Patrick, Clifford J. Rosen, Susan L. Santangelo, James C. McClay, Sally L. Hodder, the National COVID Cohort Collaborative (N3C) Consortium +17 morewiley +1 more source